Summary
Among the worldwide accepted indications for liver transplantation, inherited metabolic disorders play an increasing role. In some paediatric centres this indication runs second after extrahepatic biliary atresia.
The aim of liver transplantation in inherited metabolic disorders is twofold: the first is to save a patient's life, the second is to accomplish phenotypic and functional cure of his disease. These aims may be achieved in disorders presenting with cirrhosis, hepatoma, life-threatening progression or failure of other organs with preserved liver function. The timing of liver transplantation has become easier with development of surgical techniques of reduced-size donor livers. These techniques enable the performance of liver transplantation with ABO blood group compatible organs of almost any size if indicated either by deterioration of liver function or impending complications such as hepatoma or life-threatening progression. In comparison with other indications such as extrahepatic biliary atresia, postnecrotic liver cirrhosis or acute liver failure, the results of transplantation in patients with inherited metabolic disorders seem to be better, reaching up to 78–95% actuarial 1-year survival rates. However, lifelong immunosuppressive therapy is necessary. This seems to be acceptable even in disorders with only partial liver function defects.
Similar content being viewed by others
References
Bilheimer, D. W., Goldstein, J. L., Grundy, S. M., Starzl, T. E. and Brown, M. S. Liver transplantation to provide low-density lipoprotein receptors and lower hypercholesterolemia.N. Engl. J. Med. 311 (1984) 1658–1664
Bismuth, H. European liver transplantation registry 1989 (personal communication)
Bismuth, H. and Houssain, D. Reduced-size orthotopic liver graft in hepatic transplantation in children.Surgery 95 (1984) 367–370
Bloomer, J. R., Weimer, M. K., Bossenmaier, I. C., Snover, D. C., Payne, W. D. and Ascher, N. L. Liver transplantation in a patient with protoporphyria.Gastroenterology 97 (1989) 188–194
Brölsch, C. E., Emond, J. C., Thistlethwaite, J. R.et al. Liver transplantation with reduced-size donor organs.Transplantation 45 (1988) 519–523
Burdelski, M., Pichlmayr, R., Ringe, B., Rodeck, B. and Brodehl, J. Pediatric liver transplantation — Ten years' experience in Hanover. In: Terasaki, P. J. (ed.)Clinical Transplants UCLA Tissue Typing Laboratory, Los Angeles, 1987, pp. 55–62
Burdelski, M., Oellerich, M., Rodeck, B. and Düwel, J. Prognostic indicators in liver cirrhosis.Pediatr. Res. 27 (1990) 535
Calne, R. Y., Williams, R. and Rolles, K. Liver transplantation in the adult.World J. Surg. 10 (1986) 422–431
Casella, J. F., Lewis, J. H., Bontempo, F. A., Zitelli, B., Markel, H. and Starzl, T. E. Successful treatment of homozygous protein-C deficiency by hepatic transplantation.Lancet 1 (1988) 435–438
Cochat, P., Faure, J. L., Divry, P., Danpure, C. J., Descos, B., Wright, C., Takvorian, P. and Floret, D. Liver transplantation in primary hyperoxaluria type 1 (letter).Lancet 1 (1989) 1142–1143
Cohen, A. T., Mowat, A. P., Bhaduri, B. H., Noble-Jamieson, G., Williams, R., Barnes, N. and Calne, R. Y. Liver transplantation for inborn errors of metabolism and genetic disorders. In: Schaub, J., Van Hoof, F. and Vis, H. L. (eds.)Inborn Errors of Metabolism. Nestlé Nutrition Workshop Series, Vol. 24. Nestec Ltd., Vevey/Raven Press, New York, 1991, pp. 213–220
Coire, C. I., Qizilbash, A. H. and Castelli, M. F. Hepatic adenomata in type Ia glycogen storage disease.Arch. Pathol. Lab. Med. 111 (1987) 166–169
Daloze, P., Delvin, E. E., Glorieux, F. H., Corman, J. C., Bettez, P. and Toussi, T. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A.Am. J. Med. Genet. 1 (1977) 229–239
Danpure, C. J. Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1.J. Inher. Metab. Dis. 12 (1989) 210–224
Dehner, L. P., Snover, D. C., Sharp, H. L., Ascher, N., Nakhleh, R. and Day, D. L. Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver.Hum. Pathol. 20 (1989) 149–158
Düwel, J., Burdelski, M., Oellerich, M. and Rodeck, B. Evaluation of liver function tests as prognostic indicators in chronic pediatric liver disease.Hepatology 10 (1989) 660
Dzik, W. H., Arkin, C. F. and Jenkins, R. C. Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation.N. Engl. J. Med. 316 (1987) 1217–1218
East, C., Grundy, S. M. and Bilheimer, D. W. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.J. Am. Med. Assoc. 256 (1986) 2843–2848
Esquivel, C. O., Marino, I. R., Fioravanti, V. and van Thiel, D. H. Liver transplantation for metabolic disease of the liver.Gastroenterol. Clin. N. Am. 17 (1988) 167–175
Esquivel, C. O., Mieles, L., Todo, S., Makowka, L., Ambrosino, G., Nakazato, P. and Starzl, T. E. Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma.Transplant. Proc. 21 (1989) 2445–2446
Figuera, D., Ardaiz, J., Martin-Judez, V., Pulpon, L. A.et al. Combined transplantation of heart and liver from two different donors in a patient with familial type IIa hypercholesterolemia.J. Heart Transplant. 5 (1986) 327–329
Fung, I. J., Todo, S., Jaim, A., McCanley, J., Alessiani, M., Scotti, C. and Starzl, T. E. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.Transplant. Proc. 22 (1990) 6–12
Gartner, J. C., Bergman, I., Malatack, J. J., Zitelli, B. J. and Jaffe, R. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation.Pediatrics 77 (1986) 104–106
Gordon, R. D., Shaw, B. W., Iwatsuki, S., Esquivel, C. O. and Starzl, T. E. Indications for liver transplantation in the cyclosporine era.Surg. Clin. N. Am. 66 (1986) 541–556
Gottrand, F., Razemon, M., Otte, J. B., Vigier, J. E. and Farriaux, J. P. Indications de la transplantation hepatique au cours d'une maladie de Wilson.Arch. Fr. Pediatr. 45 (1988) 187–188
Groth, C. G. and Ringden, O. Transplantation in relation to the treatment of inherited disease.Transplantation 38 (1984) 319–327
Groth, C. G., Dubois, R. S., Corman, J.et al. Metabolic effects of hepatic replacement in Wilson's disease.Transplant. Proc. 5 (1973) 829–833
de Hemptinne, B., de Ville de Goyet, J., Kestner, P. J.,et al. Volume reduction of the liver graft before orthotopic transplantation: report of a clinical experience in 11 cases.Transplant. Proc. 19 (1987) 3317–3322
Henne-Bruns, D. and Kremer, B. Manifestation of Gilbert syndrome (Meulengracht disease) following orthotopic liver transplantation: a rare case of postoperative hyperbilirubinemia.Klin. Wochenschr. 66 (1988) 596–598
Hood, J. M., Koep, L. J., Peters, R. C.et al. Liver transplantation for advanced liver disease with α1-antitrypsin deficiency.N. Engl. J. Med. 302 (1980) 272–275
Howell, R. R. Glycogen storage disease research and clinical problems: a reappraisal.J. Pediatr. Gastroenterol. Nutr. 3 (1984) 12–13
Johnson, J. A. and Fusaro, R. M. Prognosis of liver transplantation in patients with erythropoetic protoporphyria (letter).Transplantation 48 (1989) 175–176
Kauffman, S. S., Wood, R. P., Shaw, B. W., Jr., Markin, R. S., Rosenthal, P., Gridelli, B. and Vanderhoof, J. A. Orthotopic liver transplantation for type I Crigler-Najjar syndrome.Hepatology 6 (1986) 1259–1262
Keating, J. J., Johnson, R. D., Johnson, P. J. and Williams, R. Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation.Gut 26 (1985) 1359–1363
Kreuzpaintner, G., Lauchart, W., Frenzel, H., Stremmel, W., Berges, W., Pichlmayr, R. and Strohmeyer, G. Orthotopic liver transplantation in Wilson's disease and acute liver failure.Dtsch. Med. Wochenschr. 113 (1988) 1097–1100
Kvittingen, E. A. Hereditary tyrosinemia type I — an overview.Scand. J. Clin. Lab. Invest. Suppl. 1 184 (1986) 27–32
Kvittingen, E. A., Jellum, E., Stokke, O., Flatmark, A., Bergan, A., Sodal, G., Halvorsen, S., Schrumpf, E. and Gjone, E. Liver transplantation in a 23-year-old tyrosinemia patient: effects on the renal tubular dysfunction.J. Inher. Metab. Dis. 9 (1986) 216–224
Latta, K. and Brodehl, J. Primary hyperoxaluria type I.Eur. J. Pediatr. 149 (1990) 518–522
Lewis, J. H., Bontempo, F. A., Spiro, J. A., Ragni, M. V., Starzl, T. E. Liver transplantation in a hemophiliac.N. Engl. J. Med. 312 (1985) 1189–1190
Malatack, J. J., Finegold, D. N., Iwatsuki, S., Shaw, B. W., Jr, Gartner, J. C., Zitelli, B. J., Roe, T. and Starzl, T. E. Liver transplantation for type I glycogen storage disease.Lancet 1 (1983) 1073–1075
Malatack, J. J., Schaid, D. J., Urbach, A. H., Gartner, J. C., Zitelli, B. J., Rockette, H., Fischer, J., Starzl, T. E., Iwatsuki, S. and Shaw, B. W. Choosing a pediatric recipient for orthotopic liver transplantation.J. Pediatr. 111 (1987) 479–489
Marsh, J. W., Makowka, L., Todo, S., Gordon, R. D., Esquivel, C. O., Tzakis, A., Iwatsuki, S. and Starzl, T. E. Liver transplantation today.Postgrad. Med. 81 (1987) 13–16
Martinez-Ibanez, V., Margarit, C., Tormo, R., Infante, D.et al. Liver transplantation in metabolic diseases. Report of five pediatric cases.Transplant. Proc. 19 (1987) 3803–3804
McDonald, J. C., Landreneau, M. D., Rohr, M. S. and De Vault, G. A., Jr. Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic effect.N. Engl. J. Med. 321 (1989) 1100–1103
Merion, R. M., Delius, R. E., Campbell, D. A., Jr. and Turcotte, J. G. Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B.Surgery 104 (1988) 929–931
Mieles, L., Orenstein, D., Teperman, L., Podesta, L., Koneru, B. and Starzl, T. E. Liver transplantation in cystic fibrosis.Lancet 1 (1989) 1073
Morgan, S. H. and Watts, R. M. Perspectives in the assessment and management of patients with primary hyperoxaluria type 1.Adv. Nephrol. 18 (1989) 95–106
Mowat, A. P. Liver disorders in children: the indications for liver replacement in parenchymal and metabolic disorders.Transplant. Proc. 19 (1987) 3236–3241
Oellerich, M., Burdelski, M., Lautz, H. U., Rodeck, B. and Schmidt, F. W. Assessment of short-term prognosis in transplant candidates with cirrhosis.J. Hepatol. 9 (1989a) 67
Oellerich, M., Burdelski, M., Lautz, H. U., Rodeck, B. and Düwel, J. Prognostic value of the MEGX liver function test in transplant candidates.Clin. Chem. 35 (1989b) 1130
Oellerich, M., Burdelski, M., Lautz, H. U. Prognostic sensitivity and specificity of the monoethylglycinexylidide liver function test in transplant candidates.J. Clin. Chem. Clin. Biochem. 27 (1989c) 757
Oellerich, M., Burdelski, M., Lautz, H. U., Schulz, M., Schmidt, F. W. and Herrmann, H. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.Ther. Drug. Monit. 12 (1990) 220–226
Otto, G., Herfarth, C., Senninger, N., Feist, G., Post, S. and Gmelin, K. Hepatic transplantation in galactosemia.Transplantation 47 (1989) 902–903
Pett, S. and Mowat, A. P. Crigler-Najjar syndrome types I and II. Clinical experience — King's College Hospital 1972–1978. Phenobarbitone, phototherapy and liver transplantation.Mol. Aspects Med. 9 (1987) 473–482
Pichlmayr, R., Ringe, B., Burdelski, M., Lauchart, W. and Schmidt, E. Liver transplantation in metabolic diseases.Z. Gastroenterol. (Verh.) 22 (1987) 57–60
Polson, R. J., Rolles, K., Calne, R. Y., Williams, R. and Marsden, D. Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation.Q. J. Med. 64 (1987) 685–691
Polson, R. J., Lim, C. K., Rolles, K., Calne, R. Y. and Williams, R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria.Transplantation 46 (1988) 386–389
Ringe, B., Pichlmayr, R. and Burdelski, M. A new technique of hepatic vein reconstruction in partial liver transplantation.Transplant. Int. 1 (1988) 30–35
Samuel, D., Boboc, B., Bernuau, J., Bismuth, H. and Benhamou, J. P. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoetic tissue in protoporphyrine overproduction.Gastroenterology 95 (1988) 816–819
Schade, R. R. The changing indications for liver transplantation.Transplant. Proc. 19 (1987) 2–6
Shaw, B. W., Jr., Wood, R. P., Kaufman, S. S., Williams, L., Antonson, D. L. and Vanderhoof, J. Liver transplantation therapy for children: Part 1.J. Pediatr. Gastroenterol. Nutr. 7 (1988) 157–166
Shevell, M. I., Bernard, B., Adelson, J. W., Doody, D. P., Laberge, J. M. and Guttman, F. M. Crigler-Najjar syndrome type 1: treatment by home phototherapy followed by orthotopic liver transplantation.J. Pediatr. 110 (1987) 429–431
Sokol, R. J., Francis, P. D., Gold, S. H., Ford, D. M., Lum, G. M. and Ambruso, D. R. Orthotopic liver transplantation for acute fulminant Wilson disease.J. Pediatr. 107 (1985) 549–552
Starzl, T. E. Surgery for metabolic liver disease. In: McDermott, W. V., Jr (ed.)Surgery of the Liver. Blackwell Scientific, Oxford, 1989a, pp. 127–136
Starzl, T. E. Transplantation.J. Am. Med. Assoc. 261 (1989b) 2894–2895
Starzl, T. E., Bilheimer, D. W., Bahnson, H. T., Shaw, B. W., Jr, Hardesty, R. L.et al., Heart-liver transplantation in a patient with familial hypercholesterolemia.Lancet 1 (1984) 1382–1383
Starzl, T. E., Zitelli, B. J., Shaw, B. W., Jret al. Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.J. Pediatr. 106 (1985) 604–606
Starzl, T. E., Demetris, A. J. and van Thiel, D. Liver transplantation (First of two parts).N. Engl. J. Med. 321 (1989a) 1014–1022
Starzl, T. E., Demetris, A. J. and van Thiel, D. Liver transplantation (Second of two parts).N. Engl. J. Med. 321 (1989b) 1092–1099
Sternlieb, I. Wilson's disease: indications for liver transplantation.Hepatology 4 (Suppl.) (1984) 15S-17S
Sternlieb, I. Wilson's disease: transplantation when all else has failed.Hepatology 8 (1988) 975–976
Sturm, E., Burdelski, M., Bojanowski, M., Hoeg, J. M., Tsokos, M., Schulz-Falten, J. and Bojanowski, D. Progressive intrahepatic cholestasis: a defect in apolipoprotein A-I synthesis?Hepatology 12 (2) (1990) 984
Tuchman, M., Freese, D. K., Sharp, H. L., Ramnaraine, M. L., Ascher, N. and Bloomer, J. R. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.J. Pediatr. 110 (1987) 399–403
Tuchman, M. Persistent acitrullinemia after liver transplantation for carbamylphosphate deficiency (letter).N. Engl. J. Med. 320 (1989) 1498–1499
van Thiel, D. H., Gartner, L. M., Thorp, F. K., Newman, S. L., Lindahl, J. A., Stoner, E., New M. I. and Starzl, T. E. Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.J. Hepatol. 3 (1986) 42–48
Watts, R. W., Calne, R. Y., Williams, R., Mansell, M. A., Veall, N. and Purkiss, P. Primary hyperoxaluria (type 1): attempted treatment by combined hepatic and renal transplantation.Q. J. Med. 57 (1985) 697–703
Watts, R. W., Calne, R. Y., Rolles, K., Danpure, C. J., Morgan, S. H., Mansell, M. A., Williams, R. and Purkiss, P. Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation.Lancet 2 (1987) 474–475
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burdelski, M., Rodeck, B., Latta, A. et al. Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis 14, 604–618 (1991). https://doi.org/10.1007/BF01797930
Issue Date:
DOI: https://doi.org/10.1007/BF01797930